We do it with our army of board-approved, residency trained, clinical telepharmacists, armed with years of expertise in medication administration safety and effectiveness, working night and day on the phone, video, email, and secure text message.
We do it with unparalleled software and real-time data on patients’ clinical backgrounds and medication histories, because we believe that when patient medication data is simple, accessible, and transparent at the point of care, patients can be treated from the big picture of overall health and happiness.
Because, every year, $528 Billion and 275,000 lives are lost due to poor medication management.
We do it because we've witnessed first-hand the harm that even seemingly small changes to our loved ones' prescriptions can cause, especially for the elderly and chronically ill. They are often on a complex medication regimen, taking several prescriptions from several different doctors; putting them at higher risk for adverse drug interactions, side effects, non-adherence, and care team miscommunication.
As Vice President of Product, Morgan leads Cureatr’s product and design team focusing on Cureatr’s product vision, strategy, and development of our SaaS and tech-enabled service offerings. Morgan brings 15 years of experience as a digital health product leader, building innovative and scalable health technology that has improved quality while reducing costs for patients, providers, and payers. She’s marshalled product development teams to build SaaS platforms inclusive of consumer-facing native mobile apps, enterprise web-based workflow software, analytic decision engines, AI, and integration hubs. Key accomplishments include supporting RxAnte’s successful growth from Series A funding through acquisition, being a registered Inventor on RxAnte’s RxEffect™ technology patent, increased value derived from existing offerings, resulting in substantial YOY revenue growth for ARRs $5-40M, and recruiting, developing, and coaching teams to become high functioning, customer- and user-centered, and agile. She's passionate about all things product and fostering a results-driven team culture where top talent thrives, and disruptive change is encouraged. Morgan holds a B.A. from Cornell University and a M.P.P. from the Edward Muskie School of Public Service at the University of Southern Maine.
As Chief Financial Officer, Rob Dilling leads Cureatr’s finance team focusing, on business analysis and strategic planning and finance procurement, as well as direct management of business operations including finance and accounting. Rob has demonstrated keen expertise in addressing underperformance, including restructuring operations to significantly improve cash flows. Rob has been the CFO and advisor to several private equity backed companies. His previous positions include CFO at INSCO Group, CFO at Pemco Corporation, Partner at Tatum, VP of Finance at Planar Systems Inc., CFO/VP Finance at Getronics Americas International Theater, and various Finance/Controller positions at Polaroid Corporation. Rob holds an MBA from the Darden School of Business at the University of Virginia and a BS in Electrical Engineering from West Virginia University.
With over twenty years of experience delivering results for venture capital-backed SaaS companies, Richard leads Cureatr as our CEO. Before joining our team, Richard served as CEO of GQ Life Sciences, which he led to a successful acquisition by Aptean in 2016. As a respected healthcare industry thought leader, Richard speaks publicly on trends in technology. (Be sure to check out his TED Talk, “Welcome to the genomic revolution.”) Richard holds an M.B.A. from the MIT Sloan School of Management, an M.S. in Computer Science from Worcester Polytechnic Institute, and a B.S in Computer Science from the University of Massachusetts at Amherst.
Dr. Ross is our Chief Medical Officer, a role in which he helps determine Cureatr’s clinical strategy, supports business development and market validation efforts and drives our research and measurement. A visionary physician and executive with more than 25 years of experience, Dr. Ross is a board-certified pediatrician and previously held executive positions at RxAnte, NaviNet, Prematics, and Varolii. Dr. Ross received his Bachelor of Science and MD from George Washington University, his master’s in healthcare administration from the Virginia Commonwealth University and was named “Top Doctor” by the Washingtonian Magazine.
As the company’s chief engineer Zarina is responsible for mobilizing our engineering talent to build software solutions that transform the way providers care for their patients. She is passionate about people, technology and innovation. Prior to joining Cureatr, Zarina spent the last 16 years in the healthcare and video-gaming industry working for trailblazers like Mayo Clinic, Memorial Sloan Kettering Cancer Center, AstraZeneca and Digital Chocolate Inc. As the leader of software engineering at Memorial Sloan Kettering Cancer Center, Zarina oversaw the development of germline genomics capability. Zarina holds both an MS and BS in Computer Science from Bharathiar University in Coimbatore, India and an Executive Leadership Certification from Harvard Medical School.
Working with us means working toward better, safer, more effective medication use for everyone. We have the expertise, resources, and technology to make a difference in the lives of patients and physicians. If you have similar goals, perhaps we should work together?
Health & Dental Insurance
Unlimited Vacation *
Salaried Employees Only
secure communications sent
users and growing
Getting patient medication regimens right is the single lowest-hanging fruit to drive better clinical and financial outcomes. Our vision is a world where people who need medications can access and use them safely and effectively so that they can live long healthy lives in the real world rather than the hospital.